Showing results (171-180 of 308) with videos related to
Sort By:
Pageof 31
The Journal of Biological Chemistry|August 16, 1996
The K65R mutation confers increased DNA polymerase processivity to HIV-1 reverse transcriptaseD Arion, G Borkow, Z Gu, et al.The EMBO Journal|February 15, 1994
Association of p56lck with the cytoplasmic domain of CD4 modulates HIV-1 expressionM Tremblay, S Meloche, S Gratton, et al.Antimicrobial Agents and Chemotherapy|June 1, 1993
Effect of 3'-azido-3'-deoxythymidine on human immunodeficiency virus type 1 replication in human fetal brain macrophagesR Geleziunas, E J Arts, F Boulerice, et al.Leukemia|October 1, 1995
Inhibition of human immunodeficiency virus type 1 (HIV) gag gene expression by an antisense oligodeoxynucleotide phosphorothioateM I Anazodo, M A Wainberg, A D Friesen, et al.Cancer Research|November 1, 1986
A nonviral, virus strain-specific antigen expressed on rat cells transformed by avian sarcoma virusE R Phillips, R J RuchAIDS Research and Human Retroviruses|June 27, 1998
Neutralizing antibodies directed against the V3 loop select for different escape variants in a virus with mutated reverse transcriptase (M184V) than in wild-type human immunodeficiency virus type 1P Inouye, E Cherry, M Hsu, et al.AIDS (London, England)|December 1, 1996
Effectiveness of 3TC in HIV clinical trials may be due in part to the M184V substitution in 3TC-resistant HIV-1 reverse transcriptaseM A Wainberg, M Hsu, Z Gu, et al.Journal of Virology|March 1, 1995
Sequence-specific inhibition of gene expression by a novel antisense oligodeoxynucleotide phosphorothioate directed against a nonregulatory region of the human immunodeficiency virus type 1 genomeM I Anazodo, M A Wainberg, A D Friesen, et al.In Vivo (Athens, Greece)|January 1, 1990
Infection by human cytomegalovirus and rubella virus of cultured human fetal islets of LangerhansK Numazaki, H Goldman, T A Seemayer, et al.Journal of Molecular Medicine (Berlin, Germany)|September 2, 1998
Virtues of being faithful: can we limit the genetic variation in human immunodeficiency virus?W C Drosopoulos, L F Rezende, M A Wainberg, et al.Pageof 31